101 related articles for article (PubMed ID: 22095377)
1. A new PCR-based mass spectrometry system for high-risk HPV, part I: methods.
Yi X; Li J; Yu S; Zhang A; Xu J; Yi J; Zou J; Nie X; Huang J; Wang J
Am J Clin Pathol; 2011 Dec; 136(6):913-9. PubMed ID: 22095377
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
[TBL] [Abstract][Full Text] [Related]
3. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
4. High-throughput genotyping of high-risk Human Papillomavirus by MALDI-TOF Mass Spectrometry-based method.
Cricca M; Marasco E; Alessandrini F; Fazio C; Prossomariti A; Savini C; Venturoli S; Chieco P; De Carolis S; Bonafè M; Re MC; Garagnani P; Mantovani V
New Microbiol; 2015 Apr; 38(2):211-23. PubMed ID: 25938746
[TBL] [Abstract][Full Text] [Related]
5. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
6. High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups.
Leo E; Venturoli S; Cricca M; Musiani M; Zerbini M
J Clin Virol; 2009 Aug; 45(4):304-10. PubMed ID: 19473874
[TBL] [Abstract][Full Text] [Related]
7. [The development and clinical application of papillomavirus genotyping by DNA chip].
Yang G; Liang CH; Cui JH; Chen S
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Jan; 27(1):47-9. PubMed ID: 16737573
[TBL] [Abstract][Full Text] [Related]
8. New approach to human high-risk papillomavirus (HR-HPV) genotyping.
Weismanová E; Weismann P; Vizváryová M; Lehotská V; Krizanová O; Repiská V; Kausitz J
Neoplasma; 2002; 49(4):217-24. PubMed ID: 12382018
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR.
Lin CY; Chao A; Yang YC; Chou HH; Ho CM; Lin RW; Chang TC; Chiou JY; Chao FY; Wang KL; Chien TY; Hsueh S; Huang CC; Chen CJ; Lai CH
J Clin Virol; 2008 Aug; 42(4):361-7. PubMed ID: 18455959
[TBL] [Abstract][Full Text] [Related]
10. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers.
Schmitt M; Dondog B; Waterboer T; Pawlita M
J Clin Microbiol; 2008 Mar; 46(3):1050-9. PubMed ID: 18199790
[TBL] [Abstract][Full Text] [Related]
11. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.
Perrons C; Kleter B; Jelley R; Jalal H; Quint W; Tedder R
J Med Virol; 2002 Jun; 67(2):246-52. PubMed ID: 11992586
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel microplate colorimetric hybridization genotyping assay for human papillomavirus.
Barcellos RB; Almeida SE; Sperhacke RD; Verza M; Rosso F; Medeiros RM; Perizzolo PF; Cortez-Herrera E; Rossetti ML
J Virol Methods; 2011 Oct; 177(1):38-43. PubMed ID: 21807028
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the clinical performance of the Abbott RealTime High-Risk HPV for carcinogenic HPV detection.
Halfon P; Benmoura D; Agostini A; Khiri H; Penaranda G; Martineau A; Blanc B
J Clin Virol; 2010 Aug; 48(4):246-50. PubMed ID: 20541966
[TBL] [Abstract][Full Text] [Related]
14. Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types.
Schmitz M; Scheungraber C; Herrmann J; Teller K; Gajda M; Runnebaum IB; Dürst M
J Clin Virol; 2009 Apr; 44(4):302-7. PubMed ID: 19223232
[TBL] [Abstract][Full Text] [Related]
15. HPV is detectable in virtually all abnormal cervical cytology samples after reinvestigation of HPV negatives with multiple alternative PCR tests.
Evans MF; Adamson CS; Schned LM; St John TL; Leiman G; Ashikaga T; Cooper K
Diagn Mol Pathol; 2010 Sep; 19(3):144-50. PubMed ID: 20736743
[TBL] [Abstract][Full Text] [Related]
16. [Human papilloma virus genotyping assay using restriction fragment mass polymorphism analysis, and its comparison with sequencing and hybrid capture assays].
Lee EH; Chung HJ; Oh HB; Chi HS; Jee MS; Park SN; Hong SP; Yoo W; Kim SO
Korean J Lab Med; 2007 Feb; 27(1):62-8. PubMed ID: 18094553
[TBL] [Abstract][Full Text] [Related]
17. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
18. Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer.
Stanczuk GA; Kay P; Allan B; Chirara M; Tswana SA; Bergstrom S; Sibanda EN; Williamson AL
J Med Virol; 2003 Sep; 71(1):110-4. PubMed ID: 12858416
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric GP5+/6+ PCR and hybridization with fluorescence polarization assay of 15 human papillomavirus genotypes in clinical samples.
Ju Z; Yane G; Ding L; Guowu Y; Yanhai G; Yonglan L
J Clin Virol; 2009 Feb; 44(2):106-10. PubMed ID: 19144564
[TBL] [Abstract][Full Text] [Related]
20. Rapid detection of the most common high-risk human papillomaviruses by loop-mediated isothermal amplification.
Saetiew C; Limpaiboon T; Jearanaikoon P; Daduang S; Pientong C; Kerdsin A; Daduang J
J Virol Methods; 2011 Dec; 178(1-2):22-30. PubMed ID: 21903136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
